Potential New Cause of Pediatric Cancer Identified

New Research on Pediatric Cancer Causes

Researchers at the University of Bergen in Norway have identified a potential cause of pediatric cancer. This discovery may lead to earlier detection of the disease in young children. The study, published in Frontiers in Immunology, revealed that children with pediatric cancer tend to produce autoantibodies targeting proteins essential for DNA repair.

Study Findings

The research indicates that these autoantibodies are present in higher quantities well before a cancer diagnosis. They tested samples from 175 individuals, including both adults and children with sarcoma or acute lymphoblastic leukemia. Comparisons were made with healthy individuals using data from the NoSarC Norwegian Sarcoma Study, the Norwegian Childhood Cancer Biobank, and the Oslo University Hospital Cancer Research Biobank.

Findings showed that children aged two to 19 with cancer had significantly higher levels of IgG class antibodies. These primarily targeted RAD52, NUMA1, ALKBH7, APBB1, UNG, and MGMT genes, all involved in DNA repair.

Role of Autoantibodies

Autoantibodies differ from regular antibodies as they attack the body’s own tissues. This malfunction can lead to autoimmune diseases such as type 1 diabetes, lupus, and multiple sclerosis. The precise cause of autoantibody production remains unclear, but factors may include infections, toxins, or even genetics.

Implications and Future Research

Professor Ola Myklebost noted that autoantibodies in patients could infiltrate cells and inhibit protein repair functions. This can increase the mutation rate and cancer risk. Such autoantibodies were found eight times more frequently in children who later developed cancer compared to those who did not.

Dr. Yvonne Saenger from Stony Brook University emphasized the need for further research to explore these antibodies’ impact on cellular processes. Understanding whether antibodies develop due to tumors or predispose individuals to cancer is crucial.

Conclusion

Anastassia Serguienko, another study author, suggested that these findings offer a new hypothesis on cancer development. Future work aims to establish causality and autoantibody patterns. If confirmed, screening for these antibodies could potentially predict cancer risks and lead to new treatment avenues.